Lactulose: Difference between revisions
Annhuang04 (talk | contribs) |
Annhuang04 (talk | contribs) |
||
| Line 7: | Line 7: | ||
==Adult Dosing== | ==Adult Dosing== | ||
===[[Hepatic encephalopathy]]=== | ===[[Hepatic encephalopathy]]=== | ||
* | *30-45mg PO TID or QID or (300mL in 700cc H2O retention enema x30min) | ||
**titrate for 2-3 soft stools per day | |||
===constipation=== | |||
*15-50mL PO Qday - BID | |||
**max 60mL/day | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
Revision as of 02:39, 3 September 2015
General
- Type: osmotic laxative
- Dosage Forms: 10g/15L solution
- Routes of Administration: oral, NG, rectal
- Common Trade Names: Kristalose
Adult Dosing
Hepatic encephalopathy
- 30-45mg PO TID or QID or (300mL in 700cc H2O retention enema x30min)
- titrate for 2-3 soft stools per day
constipation
- 15-50mL PO Qday - BID
- max 60mL/day
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation risk:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: